(Q34121237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Massimo Falconi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Vincenzo Valentini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

ESMO Guidelines Working Group

5 February 2020

5

object named as

ESMO Guidelines Working Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

S Jelic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

21 Suppl 5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

v55-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555103%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the cancer incidence and mortality in Europe in 2006.

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Advances in counselling and surveillance of patients at risk for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Screening and surveillance approaches in familial pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Update on 3D and multiplanar MDCT in the assessment of biliary and pancreatic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

The role of staging laparoscopy for intraabdominal cancers: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ165